Interestingly, LPA analogues, which have dual activities as ATX and LPA receptor inhibitors suppressed migration of breast cancer cells in vitro as well as tumour growth in vivo (Zhang et al, 2009). This evidence concerns the gene ENPP2 and neoplasm.